News from sanofi A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jul 29, 2020, 08:00 ET Sanofi H1 2020 business EPS(1) growth of 9.2%(2) driven by transformation

Sanofi (NASDAQ: SNY; EURONEXT: SAN) Experience the interactive Multichannel News Release here:...


Jul 22, 2020, 16:30 ET Sanofi begins shipping flu vaccines in U.S. for 2020-2021 season

Sanofi Pasteur, the vaccines global business unit of Sanofi, today shipped the first of its influenza vaccine doses to health care providers in the U....


Jul 14, 2020, 07:00 ET Sanofi and MD Anderson announce strategic collaboration to accelerate oncology research and development

Sanofi and The University of Texas MD Anderson Cancer Center today announced a five-year strategic collaboration to accelerate the development of...


Jun 19, 2020, 13:51 ET FDA approves new Dupixent® (dupilumab) pre-filled pen designed to support more convenient self-administration

The U.S. Food and Drug Administration (FDA) has approved a 300 mg single-dose pre-filled pen for Dupixent® (dupilumab). The pre-filled pen is...


Jun 15, 2020, 07:00 ET Sanofi's emerging oncology pipeline highlighted at the AACR Virtual Annual Meeting II

Preclinical data for Sanofi's investigational compounds in breast, lung, multiple myeloma and other cancers will be featured at the American Academy...


Jun 14, 2020, 10:58 ET Sanofi and Sobi donate up to 500 million additional IUs of clotting factor to WFH Humanitarian Aid Program

Sanofi and Sobi™, together with the World Federation of Hemophilia (WFH) and WFH USA, today announced an extension of their support of the WFH...


May 13, 2020, 17:00 ET Sanofi to showcase oncology portfolio and innovative pipeline at ASCO20 Virtual Scientific Program

Sanofi will present data from across its oncology franchise, including portfolio and pipeline compounds, during the upcoming American Society of...


Apr 24, 2020, 07:00 ET Sanofi at forefront of fight against COVID-19 in Q1 2020

Sanofi (NASDAQ: SNY; EURONEXT: SAN) Experience the interactive Multichannel News Release here:...


Mar 16, 2020, 08:00 ET Sanofi and Regeneron begin global Kevzara® (sarilumab) clinical trial program in patients with severe COVID-19

Sanofi and Regeneron Pharmaceuticals, Inc today announced they have started a clinical program evaluating Kevzara® (sarilumab) in patients...


Mar 02, 2020, 14:42 ET FDA approves Sarclisa® (isatuximab-irfc) for patients with relapsed refractory multiple myeloma

The U.S. Food and Drug Administration (FDA) has approved Sarclisa® (isatuximab-irfc) in combination with pomalidomide and dexamethasone (pom-dex) for ...


Feb 28, 2020, 16:21 ET Sanofi US reaches settlement agreement to resolve allegations related to patient assistance

Sanofi U.S. today announced that it has reached an $11.85 million settlement agreement with the federal government to resolve an investigation...


Feb 24, 2020, 07:44 ET Did you know sleeping naked can help promote better skin health?

Sleeping naked can help lower your body temperature, which can help you fall asleep faster, and sleep more soundly, which in turn promotes skin...


Feb 18, 2020, 10:00 ET Sanofi joins forces with U.S. Department of Health and Human Services to advance a novel coronavirus vaccine

Sanofi (NASDAQ: SNY; EURONEXT: SAN) Pasteur, the vaccines global business unit of Sanofi, will leverage previous development work for a SARS vaccine...


Feb 06, 2020, 08:00 ET Sanofi delivers strong 2019 business EPS growth of 6.8% at CER

Sanofi (NASDAQ: SNY; EURONEXT: SAN) Q4 2019 Change Change at CER 2019 Change Change at CER IFRS net sales reported €9,608m +6.8% +4.7% €36,126m +4.8% ...


Jan 30, 2020, 07:00 ET Positive topline results demonstrated by olipudase alfa, first and only investigational therapy in late-stage development for acid sphingomyelinase deficiency

Olipudase alfa, an investigational recombinant human acid sphingomyelinase, demonstrated positive results in two separate clinical trials evaluating...


Jan 23, 2020, 09:34 ET Sanofi Completes Acquisition of Synthorx, Inc.

Sanofi (NASDAQ: SNY; EURONEXT: SAN) announced today the successful completion of its acquisition of Synthorx, Inc. ("Synthorx") for $68 per share in...


Dec 09, 2019, 08:30 ET Sanofi awarded $226 million by US government to expand pandemic influenza preparedness

Sanofi Pasteur, the vaccines global business unit of Sanofi, has entered into an agreement with the U.S. Department of Health and Human Services...


Nov 21, 2019, 09:15 ET Pivotal data from Phase 3 study of sutimlimab in cold agglutinin disease to be presented at ASH 2019 late-breaking session

Full data from the pivotal Phase 3 CARDINAL trial evaluating the safety and efficacy of sutimlimab in people with primary cold agglutinin disease...


Nov 06, 2019, 09:25 ET New data to be presented at ASH 2019 highlight Sanofi's commitment to treat challenging blood cancers and rare blood disorders

New clinical data from Sanofi's oncology and rare blood disorders portfolios and pipelines will be featured, including four oral presentations and 18 ...


Nov 04, 2019, 17:30 ET FDA approves Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older

The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone® High-Dose Quadrivalent (Influenza...


Nov 04, 2019, 07:00 ET Positive results in Phase 3 trial for Toujeo® in children and adolescents with type 1 diabetes

Children and adolescents (aged 6 to 17 years) living with type 1 diabetes achieved comparable reduction in average blood sugar (HbA1c) and similar...


Oct 31, 2019, 08:00 ET Sanofi Q3 well on track

Sanofi (NASDAQ: SNY; EURONEXT: SAN) Q3 2019 Change Change at CER 9M 2019 Change Change at CER IFRS net sales reported €9,499m +1.1% -1.1% €26,518m +4....


Oct 18, 2019, 11:00 ET Sanofi to conduct precautionary voluntary recall of Zantac OTC in U.S. and Canada

As a precautionary measure, Sanofi will conduct a voluntary recall of Zantac OTC (over-the-counter) in the U.S. and Canada. This recall is being...


Oct 15, 2019, 08:00 ET Sanofi opens its first digitally-enabled, continuous manufacturing facility; ushers in next generation of biotech manufacturing

Sanofi today celebrates the inauguration of its new digital manufacturing facility in Framingham, Massachusetts, marking one of the world's first...


Sep 30, 2019, 10:30 ET New England Journal of Medicine publishes data showing improved survival with Jevtana® (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer

Data published today in the New England Journal of Medicine showed that patients with metastatic castration-resistant prostate cancer (mCRPC)...